Trending: Novartis Raises Profit Guidance as It Prepares for Patent Expirations
1137 GMT - Novartis is among the most mentioned companies across news items over the past 10 hours, according to Factiva data. The Swiss pharma company raised its profit guidance for a second time this year after profit and sales rose in the second quarter and outperformed market expectations. However, its sales target for the year remained unchanged. Novartis's Chief Financial Officer Harry Kirsch said in a media call that the company is preparing for patent expirations starting from 2025, and remains on track to achieve its mid-term sales growth and margin guidance. In particular, investors are closely watching potential generics competition to the revenue-driving heart drug Entresto--scheduled to lose patent protection next year in the U.S.--as this year's profit guidance upgrade assumes no Entresto generics coming from the U.S. Dow Jones & Co. owns Factiva. (helena.smolak@wsj.com)
(END) Dow Jones Newswires
July 18, 2024 07:53 ET (11:53 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks